IL164341A0 - Substituted amino isoxazoline derivatives and their use as anti-depressants - Google Patents
Substituted amino isoxazoline derivatives and their use as anti-depressantsInfo
- Publication number
- IL164341A0 IL164341A0 IL16434103A IL16434103A IL164341A0 IL 164341 A0 IL164341 A0 IL 164341A0 IL 16434103 A IL16434103 A IL 16434103A IL 16434103 A IL16434103 A IL 16434103A IL 164341 A0 IL164341 A0 IL 164341A0
- Authority
- IL
- Israel
- Prior art keywords
- depressants
- substituted amino
- isoxazoline derivatives
- amino isoxazoline
- derivatives
- Prior art date
Links
- XPZOKPQZEPSMFC-UHFFFAOYSA-N 4,5-dihydro-1,2-oxazol-3-amine Chemical class NC1=NOCC1 XPZOKPQZEPSMFC-UHFFFAOYSA-N 0.000 title 1
- 230000001430 anti-depressive effect Effects 0.000 title 1
- 239000000935 antidepressant agent Substances 0.000 title 1
- 229940005513 antidepressants Drugs 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
- C07D498/14—Ortho-condensed systems
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurology (AREA)
- Pharmacology & Pharmacy (AREA)
- Biomedical Technology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Psychology (AREA)
- Child & Adolescent Psychology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Hospice & Palliative Care (AREA)
- Obesity (AREA)
- Anesthesiology (AREA)
- Addiction (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP02076239 | 2002-04-02 | ||
| PCT/EP2003/003245 WO2003082878A1 (en) | 2002-04-02 | 2003-03-27 | Substituted amino isoxazoline derivatives and their use as anti-depressants. |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL164341A0 true IL164341A0 (en) | 2005-12-18 |
Family
ID=28459528
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL16434103A IL164341A0 (en) | 2002-04-02 | 2003-03-27 | Substituted amino isoxazoline derivatives and their use as anti-depressants |
| IL164341A IL164341A (en) | 2002-04-02 | 2004-09-28 | Transformed history of amino isoxazoline and their use as antidepressants |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL164341A IL164341A (en) | 2002-04-02 | 2004-09-28 | Transformed history of amino isoxazoline and their use as antidepressants |
Country Status (24)
| Country | Link |
|---|---|
| US (1) | US7265103B2 (pl) |
| EP (1) | EP1492796B1 (pl) |
| JP (1) | JP4580653B2 (pl) |
| KR (1) | KR20040093061A (pl) |
| CN (1) | CN100349897C (pl) |
| AR (1) | AR039207A1 (pl) |
| AT (1) | ATE372342T1 (pl) |
| BR (1) | BR0308309A (pl) |
| CA (1) | CA2480113C (pl) |
| DE (1) | DE60316134T2 (pl) |
| DK (1) | DK1492796T3 (pl) |
| EA (1) | EA008189B1 (pl) |
| ES (1) | ES2292949T3 (pl) |
| HK (1) | HK1080072A1 (pl) |
| HR (1) | HRP20040871A2 (pl) |
| IL (2) | IL164341A0 (pl) |
| MX (1) | MXPA04008626A (pl) |
| NO (1) | NO20044645L (pl) |
| NZ (1) | NZ536109A (pl) |
| PL (1) | PL211708B1 (pl) |
| PT (1) | PT1492796E (pl) |
| TW (1) | TWI286138B (pl) |
| WO (1) | WO2003082878A1 (pl) |
| ZA (1) | ZA200407904B (pl) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW200409777A (en) * | 2002-08-12 | 2004-06-16 | Janssen Pharmaceutica Nv | C-substituted tricyclic isoxazoline derivatives and their use as anti-depressants |
| CA2495058C (en) * | 2002-08-21 | 2012-01-03 | Janssen Pharmaceutica N.V. | C6- and c9-substituted isoxazoline derivatives and their use as anti-depressants |
| ATE443707T1 (de) | 2004-11-26 | 2009-10-15 | Janssen Pharmaceutica Nv | Isoxazolin-indol-derivate mit verbesserter antipsychotischer und anxiolytischer aktivität |
| JP2010531836A (ja) * | 2007-07-03 | 2010-09-30 | エフ．ホフマン−ラ ロシュ アーゲー | ４−イミダゾリン及びそれらの抗うつ剤としての使用 |
| JP5746631B2 (ja) | 2009-03-10 | 2015-07-08 | 武田薬品工業株式会社 | ベンゾフラン誘導体 |
| US20130062732A1 (en) | 2011-09-08 | 2013-03-14 | International Business Machines Corporation | Interconnect structures with functional components and methods for fabrication |
| CN105801510A (zh) * | 2016-04-08 | 2016-07-27 | 李勇 | 一种治疗抑郁症的药物组合物 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE68906340T2 (de) | 1988-09-19 | 1993-08-12 | Akzo Nv | Tetrahydronaphthalin und indan-derivate. |
| CA2241845C (en) * | 1996-01-05 | 2002-10-01 | Hoechst Marion Roussel, Inc. | 4,5-dihydronaphth[1,2-c]isoxazoles and derivatives thereof having cns activity |
| US6187774B1 (en) * | 1996-03-04 | 2001-02-13 | Yoshitomi Pharmaceutical Industries, Ltd. | Fused heterocyclic compounds and pharmaceutical applications thereof |
| SI1368358T1 (sl) * | 2001-02-21 | 2007-02-28 | Janssen Pharmaceutica Nv | Izoksazolinski derivati kot antidepresivi |
| TW200409777A (en) * | 2002-08-12 | 2004-06-16 | Janssen Pharmaceutica Nv | C-substituted tricyclic isoxazoline derivatives and their use as anti-depressants |
| CA2495058C (en) * | 2002-08-21 | 2012-01-03 | Janssen Pharmaceutica N.V. | C6- and c9-substituted isoxazoline derivatives and their use as anti-depressants |
-
2003
- 2003-03-27 JP JP2003580343A patent/JP4580653B2/ja not_active Expired - Fee Related
- 2003-03-27 NZ NZ536109A patent/NZ536109A/en unknown
- 2003-03-27 CN CNB038074192A patent/CN100349897C/zh not_active Expired - Fee Related
- 2003-03-27 KR KR10-2004-7012757A patent/KR20040093061A/ko not_active Ceased
- 2003-03-27 AT AT03714897T patent/ATE372342T1/de not_active IP Right Cessation
- 2003-03-27 DK DK03714897T patent/DK1492796T3/da active
- 2003-03-27 HR HR20040871A patent/HRP20040871A2/hr not_active Application Discontinuation
- 2003-03-27 IL IL16434103A patent/IL164341A0/xx unknown
- 2003-03-27 ES ES03714897T patent/ES2292949T3/es not_active Expired - Lifetime
- 2003-03-27 MX MXPA04008626A patent/MXPA04008626A/es active IP Right Grant
- 2003-03-27 BR BR0308309-8A patent/BR0308309A/pt not_active IP Right Cessation
- 2003-03-27 CA CA2480113A patent/CA2480113C/en not_active Expired - Fee Related
- 2003-03-27 PL PL371630A patent/PL211708B1/pl unknown
- 2003-03-27 EA EA200401297A patent/EA008189B1/ru not_active IP Right Cessation
- 2003-03-27 HK HK05112213.1A patent/HK1080072A1/zh unknown
- 2003-03-27 PT PT03714897T patent/PT1492796E/pt unknown
- 2003-03-27 US US10/510,220 patent/US7265103B2/en not_active Expired - Lifetime
- 2003-03-27 DE DE60316134T patent/DE60316134T2/de not_active Expired - Lifetime
- 2003-03-27 WO PCT/EP2003/003245 patent/WO2003082878A1/en not_active Ceased
- 2003-03-27 EP EP03714897A patent/EP1492796B1/en not_active Expired - Lifetime
- 2003-04-01 TW TW092107328A patent/TWI286138B/zh not_active IP Right Cessation
- 2003-04-01 AR ARP030101126A patent/AR039207A1/es unknown
-
2004
- 2004-09-28 IL IL164341A patent/IL164341A/en not_active IP Right Cessation
- 2004-09-30 ZA ZA200407904A patent/ZA200407904B/xx unknown
- 2004-10-27 NO NO20044645A patent/NO20044645L/no not_active Application Discontinuation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL173726A0 (en) | N,n-dihalogenated amino acids and derivatives | |
| PT2702871T (pt) | Biotecido de colagénio e sua utilização | |
| EP1539941A4 (en) | ADZYMES AND THEIR USES | |
| AU2003254844A1 (en) | Substituted amino compounds and use thereof | |
| PL370766A1 (pl) | Podstawione 2-aminocykloalkanokarboksyamidy i ichzastosowanie jako inhibitorów proteaz cysteinowych | |
| EP1596808A4 (en) | L-DOPA AMID DERIVATIVES AND THEIR USE | |
| IL168747A0 (en) | Oxazolidinone and/or isoxazoline derivatives as antibacterial agents | |
| IL163868A0 (en) | Hermiasterlin derivatives and uses thereof | |
| EG25683A (en) | Benzoxazine derivatives and uses thereof | |
| PL375195A1 (pl) | Pochodne aminoalkoholi | |
| PL377770A1 (pl) | Podstawione benzoksazynony i ich zastosowanie | |
| IL174479A0 (en) | Hemiasterlin derivatives and uses thereof | |
| GB0220214D0 (en) | Compounds and their use | |
| SI1551805T1 (sl) | Substituirani gama-fenil-delta-laktami in njihova uporaba | |
| IL175817A0 (en) | Benzoxazine derivatives and uses thereof | |
| IL166821A0 (en) | Novel 1,4-diazabicycloalkane derivatives their preparation and use | |
| IL157470A0 (en) | Isoxazoline derivatives as anti-depressants | |
| AU2003268075A8 (en) | Nitro and amino substituted dibenzonaphthyridines as topoisomerase agents | |
| IL164341A0 (en) | Substituted amino isoxazoline derivatives and their use as anti-depressants | |
| GB0316910D0 (en) | Fluorocombretastatin and derivatives thereof | |
| PL1786759T3 (pl) | Nowe pochodne 3,5-seko-4-norcholestanowe i ich zastosowanie | |
| GB0317376D0 (en) | Immunogenic protein and uses thereof | |
| GB0307231D0 (en) | 7-Nitroindoline derivatives and their uses | |
| EP1699809A4 (en) | PEPTIDE FROM AMNIOTIC LIQUID AND USES THEREOF | |
| EP1499338A4 (en) | 7-HYDROXY-16ALPHA-FLUORO-5-ANDROSENES-17-ONE AND 7-HYDROXY-16ALPHA-FLUORO-5-ANDROSTAN-17-ONE AND THEIR DERIVATIVES |